3.38
price up icon0.60%   0.02
after-market Handel nachbörslich: 3.38
loading

Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten

pulisher
11:43 AM

Is Cumberland Pharmaceuticals Inc. a candidate for recovery playWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com

11:43 AM
pulisher
Oct 13, 2025

How to build a dashboard for Cumberland Pharmaceuticals Inc. stockJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

Will Cumberland Pharmaceuticals Inc. stock deliver better than expected guidanceQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Can volume confirm reversal in Cumberland Pharmaceuticals Inc.Chart Signals & Precise Entry and Exit Recommendations - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

What the charts say about Cumberland Pharmaceuticals Inc. today2025 Breakouts & Breakdowns & Weekly High Potential Stock Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Is Cumberland Pharmaceuticals Inc. still worth holding after the dipMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Why Cumberland Pharmaceuticals Inc. stock is recommended by analystsEarnings Miss & Smart Allocation Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Cumberland Pharmaceuticals (NASDAQ:CPIX) - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

How to manage a losing position in Cumberland Pharmaceuticals Inc.Trade Volume Report & Low Risk Profit Maximizing Plans - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Low P/S No Reason For Excitement - simplywall.st

Oct 08, 2025
pulisher
Oct 06, 2025

Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight - GlobeNewswire Inc.

Oct 06, 2025
pulisher
Oct 06, 2025

Published on: 2025-10-06 05:25:30 - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Cumberland Pharmaceuticals Inc. benefit from macro trendsTrend Reversal & Accurate Entry/Exit Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Published on: 2025-10-06 02:33:45 - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Should you wait for a breakout in Cumberland Pharmaceuticals Inc.Earnings Trend Report & Precise Swing Trade Entry Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Sentiment analysis tools applied to Cumberland Pharmaceuticals Inc.July 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Tick level data insight on Cumberland Pharmaceuticals Inc. volatilityWatch List & High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 01, 2025

Cumberland Pharmaceuticals Announces Product Approval in Mexico - MarketScreener

Oct 01, 2025
pulisher
Oct 01, 2025

Cumberland’s injectable ibuprofen receives approval in Mexico By Investing.com - Investing.com South Africa

Oct 01, 2025
pulisher
Oct 01, 2025

Cumberland’s injectable ibuprofen receives approval in Mexico - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO - WV News

Oct 01, 2025
pulisher
Sep 29, 2025

Revolutionary Drug-Resistant Bacteria Fighter: Tabuk Brings Vibativ Antibiotic to Saudi Healthcare System - Stock Titan

Sep 29, 2025
pulisher
Sep 29, 2025

TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA - Sahm

Sep 29, 2025
pulisher
Sep 28, 2025

Is Cumberland Pharmaceuticals Inc a good long term investmentEarnings Per Share Trends & Free Long-Term Investment Planning - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What analysts say about Cumberland Pharmaceuticals Inc stockTechnical Analysis Insights & Reinvest for Maximum Compounding Returns - earlytimes.in

Sep 28, 2025
$20.22
price up icon 0.90%
$9.93
price up icon 0.71%
drug_manufacturers_specialty_generic RDY
$13.97
price down icon 2.72%
$54.02
price down icon 1.30%
$137.23
price down icon 0.09%
$433.61
price down icon 1.47%
Kapitalisierung:     |  Volumen (24h):